Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Stopping a treatment regimen that’s working can make patients nervous that the benefits will stop as well.
Progression-free survival rates were similar whether or not patients discontinued checkpoint inhibitors after remission.
People with noninvasive or early-stage breast cancer had similar outcomes whether they received radiation therapy or not.
New immunotherapies improve outcomes, but access to care and clinical trials for many still lags, notes an AACR cancer report. [VIDEO]
The American Association for Cancer Research initiative will foster collaboration and advance lifesaving scientific discoveries
Report includes call to action outlining steps Congress must take to maintain momentum.
More than a third of people with predisposition genes for breast, ovarian or colon cancer would not have qualified for genetic screening.
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets.
People treated with a durvalumab-based regimen before and after surgery had a 32% lower risk of disease recurrence or progression.
Genomic profiling showed patients with African ancestry had fewer actionable mutations and were less likely to qualify for immunotherapy.
Biliary tract cancers—rare malignancies arising in the gallbladder, bile ducts and related structures—are associated with poor outcomes.
Model using artificial intelligence accurately predicted the risk of distant recurrence in people with endometrial cancer.
REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy.
The multicancer early detection platform was developed based on methylation of cell-free DNA.
Desmoplastic melanoma, characterized by a high tumor mutation burden, may be uniquely sensitive to immune checkpoint inhibitors.
Patients who received atezolizumab (Tecentriq) plus bevacizumab (Avastin) had a 28% lower risk of cancer recurrence or death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.